Biotech

Closeup of blue eye on black background
Biotech

Lilly buys cash-strapped Adverum for eye disease gene therapy

Just as Adverum’s cash reserves were running dry, Eli Lilly has swooped in to buy the biotech and its phase 3-stage eye disease gene therapy.
James Waldron Oct 24, 2025 9:25am
Glowing puzzle piece fitting into puzzle

Biogen pens $1B deal for Vanqua's preclinical C5aR1 antagonist

Oct 24, 2025 9:15am
Carl Sailer on AI market trends and strategic planning in biotech

Carl Sailer on AI, market trends, and strategic planning in biotech

Oct 28, 2024 8:00pm
Fierce Biotechs Fierce 15

Fierce 15: Where are they now?

Oct 24, 2025 9:00am
Guidehouses Karla Anderson shares top tips for successful biotech commercialization

Guidehouse’s Karla Anderson shares top tips for successful biotech commercialization

Oct 28, 2024 8:00am
parachute sun

Former Aurion chief vaults to Valitor—Chutes & Ladders

Oct 24, 2025 8:30am